Creatine as a Menopause Treatment?
More perimenopausal and postmenopausal patients have been asking about creatine lately — not for the gym, but for the brain fog, the muscle loss, and the mood swings nobody warned them about. It's a fair question: an old, cheap sports supplement doesn't sound like a menopause treatment. The 2026 research is more interesting than the stereotype suggests.
The short version
Why women may respond differently
Creatine has spent three decades branded as a bodybuilding powder. That reputation is starting to look outdated. Women naturally store less creatine than men — they carry less muscle mass and eat less of the red meat and fish that supply it in the diet — and declining estrogen after menopause speeds up muscle and bone loss on top of that. Both of those facts point toward women plausibly getting more relative benefit from supplementing than men do, and recent trials are starting to test that directly.
What the strength data shows
A 2026 systematic review pooling seven randomized trials and 608 postmenopausal women found that creatine (at least 5 grams a day, combined with resistance training) increased lean mass by an average of 0.37 kilograms and leg-press strength by 7.5 kilograms compared with placebo. That's a modest, not dramatic, effect — and it only showed up reliably when creatine was paired with actual strength training, not taken on its own.
The cognitive picture
A separate 2024 meta-analysis of 16 randomized trials and 492 participants found creatine improved memory and processing speed, but not overall executive function. Subgroup analysis suggested the effect was larger in women than men — consistent with the idea that people who start with lower creatine stores have more room to benefit. "Brain fog" itself isn't a diagnosis, and no supplement is approved to treat it; this is about a measurable, narrow cognitive metric, not a cure-all. The CONCRET-MENOPA trial itself was small (36 women), short (8 weeks), and used a different creatine form than the strength research above, so it's an encouraging early signal rather than settled science.
Safety and dosing
The kidney-damage worry is the most persistent myth around creatine, and it doesn't hold up. Creatine supplementation raises serum creatinine as an expected biochemical byproduct, not evidence of kidney injury, and controlled studies of healthy adults taking standard doses (up to 5 grams daily) have found no effect on kidney function. Caution still applies if you already have kidney disease, are pregnant, or take other medications that affect the kidneys — that's a conversation for your provider, not a reason to avoid it if you're otherwise healthy.
Most of the muscle and bone research uses 3-5 grams of creatine monohydrate daily. The CONCRET-MENOPA brain trial used a different form (creatine hydrochloride) at a lower dose, so the two bodies of research aren't directly interchangeable yet. Higher single doses (around 10 grams) are linked to more GI upset, including diarrhea, so splitting a dose or staying in the standard range avoids most of that.
Bottom line
Creatine isn't a menopause cure, and the cognitive research especially is early and needs larger trials. But paired with resistance training, it's a low-risk, well-studied supplement with real (if modest) evidence behind it for muscle, bone, and possibly brain health in women past menopause.
Sources: CONCRET-MENOPA trial, Journal of the American Nutrition Association (2025); PubMed (2026 systematic review & meta-analysis of postmenopausal lean-mass/strength trials); Frontiers in Nutrition (2024 cognition meta-analysis); NIH/PMC reviews on creatine and renal safety.